PACS Group (PACS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
10 Jun, 2026Opening remarks and agenda
Meeting commenced with introductions of board members and executive officers in attendance.
Recognition of the independent auditor and confirmation of quorum.
Agenda and rules of conduct were made available to stockholders via the virtual portal.
Board and executive committee updates
Evelyn Dilsaver and Mark Hancock were nominated for election as Class II Directors for a term expiring in 2029.
Board and executive officers present included the CEO, President/COO, CFO, Chief Legal Officer, and Chief Accounting Officer.
Shareholder proposals
Three proposals were presented: election of directors, ratification of the independent auditor, and advisory approval of executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from PACS Group
- Q2 2026 revenue up 9.1% and net income up 49.8%, with guidance raised amid regulatory risks.PACS
Q2 2026 - Q1 2026 revenue up 11.2%, net income up 184%, and EBITDA guidance raised to $605–$625M.PACS
Q1 2026 - Virtual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance.PACS
Proxy filing - Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.PACS
Proxy filing - Record 2025 growth, strong financials, and robust M&A pipeline position the company for 2026.PACS
Oppenheimer 36th Annual Healthcare MedTech & Services Conference - 2025 revenue rose 29% to $5.29B, with strong earnings and robust 2026 growth outlook.PACS
Q4 2025 - Poised for growth with strong financials, high occupancy, and a focus on quality and innovation.PACS
44th Annual J.P. Morgan Healthcare Conference - Offering 2.78M shares at $39.67 to repay debt; founders retain control; strong growth, high regulatory risk.PACS
Registration Filing - Q2 revenue up 29% year-over-year, but net loss driven by IPO stock compensation expense.PACS
Q2 2024